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Ly6cLo non-classical monocytes 
promote resolution of rhesus 
rotavirus-mediated perinatal 
hepatic inflammation
Anas Alkhani1,4, Claire S. Levy1,4, Margaret Tsui2,4, Katherine A. Rosenberg1,4, 
Katya Polovina1,4, Aras N. Mattis3,4, Matthias Mack5, Steven Van Dyken6, Bruce M. Wang2,4, 
Jacquelyn J. Maher2,4 & Amar Nijagal1,4 ✉
Perinatal hepatic inflammation can have devastating consequences. Monocytes play an important role 
in the initiation and resolution of inflammation, and their diverse functions can be attributed to specific 
cellular subsets: pro-inflammatory or classical monocytes (Ly6cHi) and pro-reparative or non-classical 
monocytes (Ly6cLo). We hypothesized that inherent differences in Ly6cHi classical monocytes and Ly6cLo 
non-classical monocytes determine susceptibility to perinatal hepatic inflammation in late gestation 
fetuses and neonates. We found an anti-inflammatory transcriptional profile expressed by Ly6cLo 
non-classical monocytes, and a physiologic abundance of these cells in the late gestation fetal liver. 
Unlike neonatal pups, late gestation fetuses proved to be resistant to rhesus rotavirus (RRV) mediated 
liver inflammation. Furthermore, neonatal pups were rendered resistant to RRV-mediated liver injury 
when Ly6cLo non-classical monocytes were expanded. Pharmacologic inhibition of Ly6cLo non-classical 
monocytes in this setting restored susceptibility to RRV-mediated disease. These data demonstrate 
that Ly6cLo monocytes promote resolution of perinatal liver inflammation in the late gestation fetus, 
where there is a physiologic expansion of non-classical monocytes, and in the neonatal liver upon 
experimental expansion of these cells. Therapeutic strategies directed towards enhancing Ly6cLo non-
classical monocyte function may mitigate the detrimental effects of perinatal liver inflammation.
Liver inflammation can have severe, life-threatening consequences, particularly in neonates. The progressive 
nature of perinatal inflammation is at odds with the known anti-inflammatory and tolerogenic immune environ-
ment that exists in the late gestation fetal environment1–3. These observations suggest that the aggressive nature 
of liver inflammation that occurs in neonates results from impairment of the physiologic reparative mechanisms 
that exist during perinatal development.
Monocytes are innate immune cells that circulate through the bloodstream and migrate to inflamed and/
or injured tissues. Among the initial wave of leukocytes recruited to the hepatic parenchyma during liver 
inflammation4, monocytes play an important role during the initiation and resolution of the inflammatory 
response in injured tissues5. Monocytes can be separated into two main subsets based on cell surface markers. 
In mice, classical monocytes express high levels of Ly6c, whereas non-classical monocytes express low levels of 
Ly6c5. In addition to Ly6c, the differential expression of C-C motif chemokine receptor 2 (Ccr2) and C-X3-C 
motif Chemokine Receptor 1 (Cx3cr1) separates these two monocyte subsets: Ly6cHi classical monocytes are 
Ly6cHiCcr2HiCx3cr1int and Ly6cLo non-classical monocytes are Ly6cLoCcr2LoCx3cr1Hi5. Current studies support 
the idea that circulating Ly6cHi classical monocytes are recruited to sites of inflammation and injury, where they 
perform pro-inflammatory functions4,6,7. It is also believed that Ly6cHi classical monocytes transition into Ly6cLo 
non-classical monocytes, which then promote anti-inflammatory and pro-reparative functions during inflam-
mation5. In the physiologic state, Ly6cLo non-classical monocytes also act as vascular scavengers, surveilling 
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the endothelium and eliminating luminal microparticles8,9. The functions of monocytes during perinatal liver 
development and their contributions to the pathogenesis and resolution of perinatal hepatic inflammation are 
unknown.
The purpose of this study was to define the roles of Ly6cHi classical monocytes and Ly6cLo non-classical mono-
cytes during perinatal hepatic inflammation. Based on our understanding of monocyte subsets in adult tissues, we 
hypothesized that inherent differences in Ly6cHi classical monocyte and Ly6cLo non-classical monocyte function 
and their relative abundance in the liver determine susceptibility to hepatic inflammation in late gestation fetuses 
and neonates. To test this hypothesis, we performed single cell RNA sequencing to define the transcriptional pro-
file of these cells, and quantified Ly6cHi classical monocytes and Ly6cLo non-classical monocytes during perinatal 
liver development. Using a mouse model of perinatal hepatic inflammation, we determined that the abundance 
of Ly6cLo monocytes in the liver inversely correlates with disease susceptibility. Moreover, we demonstrated that 
expansion of Ly6cLo non-classical monocytes in perinatal mice renders animals resistant to an infectious insult. 
With this approach, we have defined an important role for Ly6cLo non-classical monocytes in the resolution of 
perinatal liver inflammation.
Results
Single-cell transcriptomic analysis of murine perinatal hepatic monocytes identifies a pro-in-
flammatory signature among Ly6cHi classical monocytes and an anti-inflammatory signature 
among Ly6cLo non-classical monocytes. Our current understanding of murine monocyte subsets sup-
ports the idea that Ly6cHi classical monocytes are pro-inflammatory and Ly6cLo non-classical monocytes are 
anti-inflammatory/pro-reparative5. Studies elucidating the function of monocyte subsets have predominantly 
focused on adult mice, and little is known about their function during perinatal development. We used single 
cell RNA sequencing of fetal and neonatal livers to compare the transcriptional profile of hepatic Ly6cHi classical 
monocytes and Ly6cLo non-classical monocytes during perinatal development. Using the SingleR algorithm10, we 
categorized perinatal hepatic immune populations (Fig. 1). At E15.5 and E17.5, the majority of cells were identi-
fied as erythrocytes and a fraction of cells were identified as monocytes. The prevalence of immune populations, 
including monocytes, increased in the P0 liver.
We analyzed monocytes that were identified by SingleR, and separated them by Ly6c expression into Ly6cHi 
classical monocytes and Ly6cLo non-classical monocytes (Fig. 1). Of note, Ly6c expression was highest among 
monocytes and granulocytes with low levels of expression among B- and natural killer cells (Supplementary 
Fig. 1). The separation of classical and non-classical monocytes using Ly6c expression was corroborated by 
higher levels of Ccr2 and Cd62l among Ly6cHi monocytes and higher levels of Cx3cr1 among Ly6cLo mono-
cytes5 (Supplementary Fig. 2). Using an unbiased approach, we identified numerous genes that were differen-
tially expressed between Ly6cHi classical monocytes and Ly6cLo non-classical monocytes (E15.5, 85 genes; E17.5, 
71 genes; P0, 92 genes, Fig. 2a). We categorized these differentially expressed genes by identifying the cellular 
pathways in which they are involved using the REACTOME database11 (Fig. 2b). Ly6cHi classical monocytes and 
Ly6cLo non-classical monocytes had differential expression of genes involved with immune function at all three 
time points, along with basic cellular functions including metabolism and signal transduction (Fig. 2b). Ly6cLo 
monocytes had elevated expression of interferon-induced transmembrane protein 1 (Ifitm1), which is involved 
with the antiviral response to limit viral entry into the cytosol, and Cd74, a receptor for Mif that is respon-
sible for initiating cell survival pathways and cellular proliferation (Fig. 2c). These transcripts were expressed 
at high levels in Ly6cLo non-classical monocytes at all three time points. Several pro-inflammatory genes were 
expressed at a higher level in Ly6cHi classical monocytes than in Ly6cLo non-classical monocytes, including mem-
bers of the s100 calcium-binding protein family A8, A9, and A11, and ficolin-beta (Fcnb). We also examined 
known pro-inflammatory and pro-reparative mediators, and found elevated expression of anti-inflammatory 
and pro-reparative genes (Il4ra and Tgfb1) in Ly6cLo monocytes, and elevated levels of pro-inflammatory 
genes (Mmp8, S100a1, Irf5, Naip2, Casp1, Card9, Ifngr1, Ifngr2, Ifi204, Ifitm2, Ifitm3, and Ifitm6) in Ly6cHi 
monocytes (Supplementary Fig. 3). The lower levels of pro-inflammatory mediators and higher expression of 
anti-inflammatory/reparative transcripts in Ly6cLo monocytes support the hypothesis that these cells may pro-
mote resolution of perinatal liver inflammation.
Ly6cLo non-classical monocytes outnumber Ly6cHi classical monocytes in the late gestation fetus. 
We then quantified the proportion of Ly6cHi classical monocytes and Ly6cLo non-classical monocytes in the liver 
to determine the relative abundance of both populations during perinatal development. To define the propor-
tion of monocyte subsets, we first characterized leukocytes, including monocytes, tissue macrophages, conven-
tional dendritic cells, and neutrophils residing in the livers of late gestation fetuses and neonatal pups (Fig. 3a, 
Supplementary Fig. 4). As a reference lymphoid organ, we also examined the leukocyte composition of the spleen 
during these time points (the spleen was not visible in the late gestation, E17.5 fetus). Cd45+ leukocytes com-
prised 15.8% of the total cells in the E17.5 fetal liver with the proportion of leukocytes increasing to 60.7% of total 
cells at the time of birth, likely resulting from the rapid expansion of hematopoietic progenitor cells that occurs 
in the late gestation fetal liver (Fig. 3b)12. The absolute number of leukocytes also fluctuated during this period, 
peaking at day 10. Leukocyte percentages in the spleen ranged between 73.8% and 61.9%, with a nadir 7 days after 
birth (36.8%) (Fig. 3c). In concordance with its development as a lymphoid organ during postnatal life, the cellu-
larity of the spleen increased through all the time points tested. Cd45+Cd11b+Ly6g-Cd64- monocytes comprised 
~21.0% of the total leukocyte pool in the late gestation fetal liver (Fig. 3d). Total monocyte percentages were high 
in the late gestation fetus, decreased at birth (4.9%), re-expanded, albeit to lower levels than at E17.5 (14.2%), and 
decreased again after day 7 to 6.0%. The absolute number of monocytes increased in the liver with a peak at day 7, 
likely reflecting the expansion of leukocytes seen in the postnatal liver (Fig. 3b). We noticed a similar trend in the 
spleen, as monocyte percentages remained low at birth (7.3%) and at P3 (5.8%), before spiking at day 7 (12.5%) 
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and plateauing at day 14 (6.4%) (Fig. 3e). The absolute number of monocytes in the spleen mirrored the propor-
tion of monocytes, also peaking at day 7.
Given the importance of monocyte subsets in the initiation and resolution of inflammation, and their abun-
dance in the late gestation fetus, we quantified the proportions of Ly6cLo non-classical monocytes and Ly6cHi 
classical monocytes during late gestation fetal and neonatal development. We observed that Ly6cLo non-classical 
monocytes are the predominant monocyte population in late gestation fetal liver (Fig. 3f). Whereas Ly6cHi classi-
cal monocytes account for 1.1% (±0.10%) of total leukocytes at E17.5, Ly6cLo non-classical monocytes comprise 
2.9% (±0.10%) of leukocytes. This difference in the proportions of monocyte subsets was reflected by the absolute 






































































































Figure 1. scRNAseq of murine perinatal immune cells and separation of classical and non-classical monocytes 
based on Ly6c expression. Single cell RNA sequence analysis was performed of the perinatal liver at E15.5, 
E17.5, and P0. Left panel: Using the SingleR algorithm, perinatal hepatic immune and non-immune populations 
were defined. Middle panel: Monocytes were identified and further sub-clustered. Right panel: Monocytes with 
Ly6c2 expression >1.5 (log-normalized counts) were classified as Ly6cHi classical monocytes; those with Ly6c2 
expression less than 1.5 (log-normalized counts) were classified as Ly6cLo non-classical monocytes. Dashed line 
denotes gene expression at 1.5x log-normalized counts.
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monocytes in the late gestation fetal liver. The proportions of each of these cell types equalized at the time of deliv-
ery in the liver (Fig. 3f), approaching the eventual 1:1 ratio of Ly6cLo:Ly6cHi monocytes that exists in circulation 
(Fig. 3g)5.
The physiological abundance of Ly6cLo non-classical monocytes correlates with resistance to 
periportal inflammation. The anti-inflammatory transcriptional profile of perinatal Ly6cLo non-classical 
monocytes and their relative abundance at E17.5 led us to question whether Ly6cLo non-classical monocytes 
confer resistance to perinatal inflammation in the late gestation fetus. To study the role of Ly6cHi classical mono-
cytes and Ly6cLo non-classical monocytes during perinatal hepatic inflammation, we used rhesus rotavirus (RRV) 
infection to induce perinatal liver injury and to determine whether physiological differences in the abundance of 
Ly6cLo non-classical monocytes and Ly6cHi classical monocytes affects susceptibility. The RRV model of perinatal 
liver inflammation has been used to study the mechanism(s) of immune-mediated periportal inflammation and 
bile duct obstruction in neonatal animals13. Similar to previously published results, intraperitoneal injection of 
1.5 × 106 focus-forming units (ffu) RRV during the first 24 hours of life resulted in the development of jaundice 
Genes that are expressed above the 0.5 threshold in Ly6cHi monocytes
Genes that are expressed above the 0.5 threshold in Ly6cLo monocytes



















































































































































































































































































































































































































































































































Figure 2. Functional annotation of scRNAseq analysis of murine perinatal hepatic monocytes demonstrates 
differential expression of several genes in immune system pathways among Ly6cHi and Ly6cLo monocytes. 
(a) Number of differentially expressed genes between Ly6cHi classical monocytes and Ly6cLo non-classical 
monocytes from each timepoint (E15.5, E17.5, and P0) and (b) Venn diagram of functional pathway 
annotations. (c) Expression of genes of interest in immune-related functional pathways defined in (a).
5Scientific RepoRtS |         (2020) 10:7165  | https://doi.org/10.1038/s41598-020-64158-2
www.nature.com/scientificreportswww.nature.com/scientificreports/
(Fig. 4a) and death in the majority of animals (79% mortality, median survival 17 days, Fig. 4b)13,14. Neonatal 
pups experienced progressive weight loss 7 days after RRV infection compared to PBS controls (Fig. 4c). Infected 
animals developed periportal inflammation 7 days after infection, with progression to tissue necrosis until the 
majority of animals succumbed to their illness (Fig. 4b,f). This infectious model of periportal inflammation 
resulted in inflammation only in the liver, without affecting other organs (Supplementary Fig. 5). Of note, there 
was no inflammation or mucosal sloughing of the small and large intestine observed, despite the known effects of 
rotavirus on the gastrointestinal system (Supplementary Fig. 5)15.
To determine whether the relative abundance of Ly6cLo non-classical monocytes we identified in the late ges-
tation fetus is associated with resistance to RRV-mediated liver inflammation, we adapted the neonatal model 
of RRV infection to the fetal environment using fetal surgical techniques that we have previously described16,17. 
E14.5 fetuses were infected with RRV and subsequently tracked for survival and development of liver disease. 
Over 75% of live-born mice infected with RRV in utero (79.1%, n = 38/43) lived beyond 21 days, which was sig-
nificantly higher than the proportion surviving after postnatal RRV infection (p < 0.0001, Fig. 4b). In contrast to 
the weight loss we observed in RRV-infected neonatal pups (Fig. 4c), fetuses injected with RRV did not develop 
neonatal growth restriction (Fig. 4d), corroborating our findings that fetuses exposed to RRV are resilient to 
RRV-mediated injury. We confirmed that the improved survival of prenatally-infected mice was not due to a fail-
ure of RRV infection: indeed, a similar proportion of animals that underwent fetal and postnatal RRV infection 





























i.   Cd45+ leukocytes
ii.  Ly6g+ MHCII- (neutrophils)
iii. Cd64+ Cd11b-/low (tissue macs)
iv. Cd11b+Ly6g- (monocytes)
v.  Cd11b-Cd11c+MHCII+ (cDC)
vi.  Cd11b+Ly6cLo
      (non-classical monocytes)
vii. Cd11b+Ly6cHi





























































































































































































































































Figure 3. Physiological abundance of Ly6cLo non-classical monocytes compared to Ly6cHi classical monocytes 
in the late gestation fetal liver. (a) Ly6cLo monocytes, Ly6cHi monocytes, and other leukocyte populations were 
identified by flow cytometry. (b,c) The overall proportion of Cd45+ leukocytes is relatively low in the late 
gestational fetal liver (E17.5, n = 11), then increases by day of birth (P0, n = 9), and plateaus (P3, n = 6; P7, 
n = 9; P10, n = 6; P14, n = 7), whereas the proportion in the spleen stays relatively stable (P0, n = 6; P3, n = 6; 
P7, n = 9; P10, n = 6; P14, n = 7. (d,e) Cd11b+ monocytes were identified and are at their highest abundance of 
the Cd45+ leukocyte compartment in the late gestational liver (E17.5, n = 11). They then decrease at birth (P0, 
n = 6), rise again to a level that is between the two earlier time points (P3, n = 6; P7, n = 9), and then decrease 
to day of birth levels (P10, n = 6; P14, n = 4). In the spleen, Ly6cLo non-classical monocytes remained low at 
birth and peaked at P7. (f-g) There is a physiological abundance of Ly6cLo non-classical monocytes compared 
to Ly6cHi classical monocytes at E17.5 in the liver that is not observed in the spleen (p-value%: <0.0001 (****), 
p-value#: 0.0007 (***)). Data represent mean +/− SEM.





























































































































Condition (n’s) Grade 0-1 (n’s) Grade 2-3 (n’s)
χ2 c.t RRV alone
(Grade 0-1/Grade 2-3)
RRV (Postnatal) (27) 45.0% (12) 55.0% (15) ----------
RRV (Fetal) (30) 97.0% (29) 3.0% (1)
g)
1.7X10-5 / 1.0X10-4
Figure 4. The physiological abundance of Ly6cLo non-classical monocytes in the late gestation fetus 
inversely correlates with susceptibility to periportal inflammation. (a) Images of P14 Balb/c pups demonstrate 
the phenotypic changes (jaundice, growth restriction, and weight loss) associated with postnatal RRV-infection 
compared to PBS controls. (b) Survival of live-born pups after fetal RRV infection was significantly higher than 
for neonates infected with RRV (postnatal RRV: n = 15/73, 20% survival, Chi-square = 1.1 × 10−11 c.t. PBS 
controls; fetal RRV: n = 38/43, 88% survival, Chi-square = 1.0 × 10−22 c.t. postnatal RRV; Kaplan-meier survival 
curve, fetal RRV c.t. postnatal RRV, p-value <0.0001). (c) RRV-infected pups experienced significant weight 
loss (n = 73) compared to PBS controls (n = 27). (d) Unlike animals that undergo postnatal RRV infection 
(n = 73), fetuses infected with RRV do not experience neonatal growth restriction. Data represent mean 
+/− SEM. (p-value: <0.05 (*), <0.01 (**), <0.001 (***), <0.0001 (****)). (e) Viral titers from infected livers 
were calculated to determine the proportion of livers that had infectious viral particles. Quantification of viral 
titers was also determined in those livers that had infectious particles. Data represent at least 2 independent 
experiments and at least 9 animals per group. Error bars represent the mean +/- SEM. (f) Hematoxylin & Eosin 
(H&E) stained sections demonstrate higher grade of periportal inflammation and necrotic foci formation after 
RRV-mediated liver injury in postnatal pups one week (n = 6) and two weeks (n = 4) after infection compared 
to fetal RRV infection, one week (n = 6) and two weeks after infection (n = 2). Fetal RRV samples demonstrate 
a similar degree of extramedullary hematopoiesis in the early neonatal stage when compared to PBS controls. 
Black arrows point to periportal inflammation in liver samples after RRV-mediated liver injury. Red arrow 
points to necrotic foci in liver samples after RRV-mediated liver injury. (g) Grading of periportal inflammation 
in liver tissue samples after postnatal (n = 27) and fetal (n = 30) RRV infection.
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infection (Fig. 4e). Histological analysis of livers 2 weeks after RRV infection showed minimal periportal inflam-
mation after fetal infection compared to postnatal infection (Fig. 4f). We compared the grade of inflammation 
after postnatal and fetal RRV infection in a blinded fashion and found fewer mice with grade 2–3 inflammation 
after fetal RRV infection (Fig. 4g). A similar degree of extramedullary hematopoiesis was present in fetal livers 1 
week after RRV infection and in fetal PBS control livers (Fig. 4f). Additionally, we found fewer necrotic foci after 
fetal RRV infection compared to postnatal infection (data not shown). These data demonstrate that fetuses are 
resistant to RRV-mediated infection despite effective delivery of RRV and establishment of infection, supporting 
our hypothesis that physiologic differences in monocyte composition may account for resilience in the late ges-
tation fetus.
T- and B-lymphocytes are not required for RRV-mediated inflammation, and may play a pro-
tective role during the later stages of RRV-mediated inflammation. Our data support the role of 
myeloid populations, and specifically monocytes, in the pathogenesis of RRV-mediated inflammation. In addition 
to the myeloid compartment, other immune mediators, including type 2 immune responses and the adaptive 
immune system, have been implicated in the pathogenesis of RRV-mediated inflammation14,18–21. Type 2 immu-
nity was not required for establishing disease after RRV infection, as mice deficient in thymic stromal lympho-
poietin receptor, IL-33 receptor, and IL-25 had similar survival, weight loss, and inflammation when compared to 
wildtype controls (Supplementary Fig. 6). To determine whether T- and B-cells contribute to the pathogenesis of 
RRV-mediated perinatal liver inflammation, we infected neonatal RAG KO (deficient in T- and B-lymphocytes) 
pups with RRV. We found that there was no difference in survival during the first 2 weeks after infection com-
pared to immunocompetent wildtype animals (Fig. 5a). RAG KO animals did, however, have a survival disad-
vantage 14 days after RRV infection. This pattern of mortality is in stark contrast to that of RRV-infected fetuses, 
for which there is a survival advantage in the early stages of infection, thus supporting the idea that monocytes 
may impact disease susceptibility during the early phase of RRV-mediated inflammation. Similar to wildtype 
mice, RAG KO animals experienced weight loss and periportal inflammation (Fig. 5b,c). Collectively, these data 
support a limited role of the adaptive immune system and type 2 immunity in the pathogenesis of RRV-mediated 
inflammation.
Experimental ablation of Ly6cHi classical monocytes and neutrophils results in the expansion 
of Ly6cLo non-classical monocytes during RRV-mediated periportal inflammation and confers 
protection from disease. Having demonstrated a correlation between the physiologic abundance of Ly6cLo 
non-classical monocytes in the late gestation fetus and resistance to periportal hepatic inflammation, we hypoth-
esized that if Ly6cLo monocyte numbers in the neonatal liver could be increased experimentally to prenatal levels, 
then postnatal animals would be rendered similarly resistant to perinatal liver inflammation. Using antibodies 
that target receptors expressed on Ly6cHi monocytes and neutrophils, we depleted these two pro-inflammatory 
populations individually and quantified the effects on Ly6cLo non-classical monocytes (Fig. 6a,b). In addition to 
expressing Ly6c, Ly6cHi monocytes also express high levels of Ccr2. This cell surface molecule can be used as a 
target for antibody-mediated depletion of Ly6cHi classical monocytes22 (Supplementary Fig. 7). Administration of 
anti-Ccr2 (clone MC21) in the setting of RRV infection led to the elimination of >60% of Ly6cHi classical mono-
cytes compared to RRV-infected livers without Ly6cHi classical monocyte depletion (Fig. 6b,c). We examined the 
impact of Ly6cHi classical monocyte depletion on hepatic Ly6cLo non-classical monocytes, and observed that even 
though the proportion of Ly6cLo monocytes did not change, the Ly6cLo: Ly6cHi monocyte ratio increased (Fig. 6d).
Anti-Ly6g (clone 1A8, BioX-cell) was used to deplete neutrophils, and resulted in ~90% reduction of neu-
trophils during RRV infection (Fig. 6e, Supplementary Fig. 7). When neutrophils were depleted, we observed 
an increase in the proportion of Ly6cLo non-classical monocytes, although it was not statistically significant 
(Fig. 6e). We did, however, observe a significant increase in the absolute number of Ly6cLo non-classical mono-
cytes in RRV-infected livers when neutrophils were depleted (Fig. 6f). This expansion did not result in a change 
c)




































s) WT  
RAG KO
Figure 5. Adaptive immune cells play a protective role during the later stages of RRV-mediated inflammation. 
(a) Kaplan-Meier survival after RRV infection in WT (n = 40) and RAG KO (n = 19) animals. RAG KO animals 
have similar rates of survival compared to WT during the first 2 weeks of infection. There is an increase in 
mortality in RAG KO animals that is apparent during the latter phase of RRV infection (p-value 0.006). (b) 
Weight over time of WT pups injected with RRV (n = 73) compared to RAG KO pups injected with RRV 
(n = 19). Data represent the mean +/−SEM. (c) Hematoxylin and eosin (H&E) stained sections demonstrate 
histological changes within the liver tissue of postnatal pups two weeks after injection with RRV, (left to right): 
WT (n = 4), RAG KO (n = 5). Black arrows point to periportal inflammation in liver samples after RRV-
mediated liver injury. Red arrow points to necrotic foci in liver samples after RRV-mediated liver injury.
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in the Ly6cLo: Ly6cHi monocyte ratio (Fig. 6g). We predicted that if both neutrophils and Ly6cHi classical mono-
cytes were depleted simultaneously, than we would observe an increase in both the absolute number of Ly6cLo 
non-classical monocytes and the ratio of Ly6cLo: Ly6cHi monocytes. Indeed, when Ly6cHi classical monocyte - and 
neutrophil-depleting antibodies were administered simultaneously (double depletion, DD), there was a signif-
icantly higher proportion of Ly6cLo non-classical monocytes in RRV-infected livers (Fig. 6h). Furthermore, the 
ratio of Ly6cLo: Ly6cHi monocytes was higher after the simultaneous depletion of neutrophils and Ly6cHi clas-
sical monocytes (RRV alone 1.6; RRV with DD 42.8; Fig. 6i), thereby resembling the late gestation fetal liver 
where there is an abundance of Ly6cLo non-classical monocytes. Of note, simultaneous depletion of neutrophils 
and Ly6cHi classical monocytes had no statistically significant effect on dendritic cells and tissue macrophages 
(Supplementary Fig. 8).
We then tested our hypothesis by depleting Ly6cHi monocytes and neutrophils in RRV-infected animals to see 
if the observed expansion of Ly6cLo monocytes conferred protection against RRV-mediated perinatal inflamma-
tion. Indeed, when both Ly6cHi classical monocytes and neutrophils were depleted, neonatal pups were rescued 
from RRV-mediated injury (Fig. 6j). Correspondingly, pup weights were significantly higher compared to RRV 
infection alone at time points when neonatal mice normally exhibit growth restriction due to RRV infection 
(Fig. 7d). Furthermore, treatment with both anti-Ccr2 and anti-Ly6g led to a significant increase in the number of 
animals with grade 0–1 periportal inflammation and fewer mice with grade 2–3 inflammation compared to those 
treated with RRV alone, and in the majority of cases, there was near resolution of disease (Fig. 7e,f). Survival rate 
Figure 6. Ly6cLo non-classical monocytes promote resolution of RRV-mediated periportal inflammation.  
(a) Dosage schedule illustrating regimen used to deplete Ly6cHi classical monocytes (anti-Ccr2) and neutrophils 
(anti-Ly6g), and to inhibit Ly6cLo non-classical monocytes (Cx3cr1 small molecular inhibitor, AZD8797) after 
inducing RRV-mediated liver injury in neonatal pups. (b–d) Depletion via anti-Ccr2 led to a 76% reduction of 
Ly6cHi classical monocytes in the Cd45+ leukocyte compartment, which did not affect the proportion of Ly6cLo 
non-classical monocytes (RRV n = 11, RRVanti-Ccr2 n = 10) and a 95% reduction of the absolute number of Ly6cHi 
classical monocytes expected in a P7 liver. This led to a statistically significant increase in the ratio of Ly6cLo: 
Ly6cHi monocytes (p-value 0.026 (*)). (e-g) Depletion of neutrophils alone (p-valueE: <0.0001 (****), p-valueF: 
0.048 (*)) led to an expansion of Ly6cLo non-classical monocytes, (p-valueF: 0.04 (*)), but did not change the 
ratio of Ly6cLo: Ly6cHi monocytes ((d) RRV n = 14, RRVanti-Ly6g n = 7, (e) RRV n = 4, RRVanti-Ly6g n = 4). (h–j) 
Depleting both Ly6cHi classical monocytes (p-value: 0.0207 (*)) and neutrophils (p-value: <0.0001 (****)) 
(Double Depletion, DD) led to further expansion of Ly6cLo non-classical monocytes (p-value: <0.0001 (****)) 
(n = 4) and a significantly higher survival rate when compared to RRV alone (p-value 0.0002) or RRV plus 
single depletion (RRV n = 49, RRV Ly6cHi classical monocytes depletion n = 13, RRVneutrophil depletion n = 19, RRVDD n = 16). 
Data represent mean +/− SEM. (p-value: <0.05 (*), <0.0001 (****)).
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after either Ly6cHi monocyte or neutrophil depletion was lower than for Ly6cHi monocyte and neutrophil-replete 
controls (Ly6cHi monocyte depletion: median survival: 14 days for RRV + Ly6cHi monocyte depletion vs. 17 days 
for RRV alone, p-value 0.0012; neutrophil depletion: median survival: 13 days for RRV + neutrophil depletion 
vs. 17 days for RRV alone, p < 0.0001, Fig. 6j), indicating that the absence of both neutrophils and Ly6cHi classical 
monocytes is necessary to confer resistance.
Ly6cLo non-classical monocytes promote resolution of RRV-mediated liver inflamma-
tion. Although our results support the idea that expansion of Ly6cLo non-classical monocytes, in the 
experimental setting of Ly6cHi classical monocyte and neutrophil depletion, promotes resolution of neonatal 
periportal inflammation, we questioned whether the improvement in survival we observed was due to unop-
posed pro-reparative Ly6cLo monocyte function or whether it was due to the absence of pro-inflammatory Ly6cHi 
classical monocytes and neutrophils. Our transcriptional analysis of perinatal Ly6cLo non-classical monocytes 
supported the former, and we therefore hypothesized that inhibiting Ly6cLo monocytes in the setting of Ly6cHi 
monocyte- and neutrophil-depletion, would restore susceptibility to RRV infection. Based on the high level of 
Cx3cr1 expression in Ly6cLo non-classical monocytes8,9 we used the high-affinity Cx3cr1 small molecule inhib-
itor, AZD879723–25, to test whether Cx3cr1 inhibition would reduce numbers of Ly6cLo non-classical monocytes 
and restore susceptibility to RRV-mediated inflammation (Fig. 6a). Indeed, Ly6cLo non-classical monocyte 
proportions significantly decreased when AZD8797 was given in conjunction with anti-Ly6g and anti-Ccr2 
(Fig. 7a), resulting in a decrease in Ly6cLo:Ly6cHi monocyte ratios (Fig. 7b). These results are in agreement with 
the known mechanism of AZD8797 as a non-competitive modulator of Cx3cr1 that also inhibits downstream 
Cx3cr1-mediated G-protein signaling, thus resulting in a combination of diminished recruitment and func-
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Figure 7. Inhibition of Ly6cLo non-classical monocytes restores susceptibility to RRV-mediated periportal 
inflammation. (a–d) Addition of AZD8797 had no effect on depleted Ly6cHi classical monocytes and 
neutrophils (n = 4), but did significantly reduce the Ly6cLo non-classical monocytes expansion observed in the 
DD group (p-value: 0.0303 (*)) and led to restoration of RRV susceptibility and observed weight loss (RRV 
n = 49, RRVDD n = 16, RRVDD + AZD8797 n = 21). (e) Hematoxylin and eosin (H&E) stained sections demonstrate 
histological changes within the liver tissue of postnatal pups 3 weeks after injection with, (left to right): RRV 
only (n = 8), DD (n = 13), and DD + AZD8797 (n = 4). DD samples showed resolution of inflammation and 
absence of necrotic injury when compared to DD + AZD8797, which showed higher grade of inflammation 
and the presence of necrotic injury. Black arrows point to periportal inflammation. Red arrows point to 
necrotic foci. ((p-value: <0.05 (*), <0.01 (**), <0.001 (***)). Data represent mean +/−SEM. (f) Grading of 
periportal inflammation in liver tissue samples after RRV-mediated liver injury (n = 27), RRV + DD (n = 13), 
RRV + DD + AZD8797 (n = 5). Liver samples of pups injected with RRV + DD have less inflammation when 
compared to liver samples of pups injected with RRV alone. X2 c.t RRV alone = 0.029/0.050.
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macrophages, although this reduction did not result in a statistically significant difference (Supplementary Fig. 8). 
Notably, when Ly6cLo non-classical monocytes were decreased in the absence of neutrophils and Ly6cHi mono-
cytes, susceptibility to RRV-mediated inflammation was restored (Fig. 7c). Survival after AZD8797 treatment 
was similar to survival after RRV alone and significantly lower than survival after Ly6cHi classical monocytes 
and neutrophil depletion (RRV + DD + AZD8797: median survival 15 days, p-value 0.80 c.t. RRV alone, p-value 
0.008 c.t. RRV + DD). Whereas RRV + DD pup weights were significantly higher compared to RRV infection 
alone at a time when neonatal mice exhibit growth restriction due to RRV infection, RRV + DD + AZD8797 pup 
weights decreased, similar to that observed in RRV alone (Fig. 7d). Additionally, the grade of inflammation in the 
setting of DD + AZD8797 was similar to that seen after RRV alone (Fig. 7e,f). These findings demonstrate that the 
abundance of Ly6cLo non-classical monocytes is associated with resolution of RRV-mediated inflammation, and 
that the reduction of these cells when AZD8797 is administered restores suseptibility to RRV-mediated injury. 
Although our data does not definitively prove that the disease resolution we observe with AZD8797 treatment 
occurs from its direct effect on Ly6cLo non-classical monocytes, these data support the idea that the abundance of 
Ly6cLo non-classical monocytes promotes resolution of RRV-mediated perinatal liver inflammation.
Discussion
In this study, we hypothesized that inherent differences in Ly6cHi classical monocyte and Ly6cLo non-classical 
monocyte function, and their relative abundance in late gestation fetuses and neonatal pups, determine sus-
ceptibility to perinatal hepatic inflammation. Our results demonstrate that (i) Ly6cLo non-classical monocytes 
express a pro-reparative transcriptomic signature during the perinatal period and their abundance inversely cor-
relates with susceptibility to RRV-mediated perinatal liver injury, (ii) the adaptive immune system and type 2 
immunity play a limited role in inflammation after RRV infection, and (iii) experimental manipulation of Ly6cLo 
non-classical monocytes can render neonatal pups resistant to perinatal liver injury. Collectively, these results 
support the conclusion that Ly6cLo non-classical monocytes play an important role in promoting the resolution 
of RRV-mediated perinatal inflammation.
Individual immune subsets have been implicated as being important for the pathogenesis of RRV-mediated 
perinatal liver inflammation, including effector T cells14,21,26,27, regulatory T cells28,29, B cells20, natural killer cells30, 
and dendritic cells31. Using RAG KO mice, we examined the contribution of the adaptive immune system in the 
pathogenesis of RRV-mediated inflammation. The equivalent survival between RAG KO and wildtype animals 
during the first 14 days of injury suggests that the main contribution of the adaptive immune system to the resolu-
tion of inflammation is limited to later in the disease course. The similar degree of inflammation and survival we 
observed in type 2 immune deficient animals compared to wildtype animals does not eliminate the role of type 2 
immunity during perinatal liver inflammation, as liver-specific cues or other type 2-activating pathways including 
IL-4 and the tissue alarmins Hmgb1, S100 family proteins, and IL-1alpha could play roles in disease pathogenesis.
A prime example of a disease involving neonatal liver inflammation is biliary atresia (BA), for which treatment 
options are limited due to our lack of understanding of the pathophysiology of perinatal liver inflammation in 
this setting. Although an immune-mediated component is thought to potentiate bile duct obstruction in patients 
with BA, non-specific immunosuppression through corticosteroids and antibody depletion through intravenous 
immunoglobulin have failed to demonstrate a difference in survival in patients with BA who undergo Kasai por-
toenterostomy32–34. Furthermore, these clinical interventions have been restricted to the postnatal environment 
and little is known about the prenatal factors that may contribute to susceptibility to disease, despite the com-
pelling evidence that BA has fetal origins35. Our results demonstrate that the naturally occurring differences in 
inflammatory and reparative monocyte subsets during gestation may contribute to susceptibility and resilience 
to perinatal liver injury. The lack of clinical efficacy of corticosteroids in human BA could be further explained by 
the fact that glucocorticoid administration selectively inhibits human CD14+CD16+ non-classical monocytes36. 
We speculate that the underlying mechanisms that predispose patients to perinatal liver diseases like BA may be 
due to alterations in normal immune mechanisms that facilitate restoration of tissue homeostasis. Further work 
to define monocyte subsets and function in human perinatal liver inflammation will be needed to understand the 
role of Ly6cHi classical monocytes and Ly6cLo non-classical monocytes in human BA.
In addition to demonstrating a pro-reparative role for Ly6cLo non-classical monocytes during perinatal liver 
injury, our results also demonstrate that Ly6cLo non-classical monocytes expand and play a role in tissue repair 
even when Ly6cHi classical monocytes are depleted. Other models of tissue inflammation have demonstrated 
that Ly6cHi classical monocytes transition into Ly6cLo non-classical monocytes at the site of injury to support 
the restoration and repair of the tissue37–39. Our results challenge the concept that Ly6cHi monocytes serve as 
precursors to Ly6cLo monocytes;38,40–42 they suggest either that Ly6cLo non-classical monocytes develop without 
passing through the Ly6cHi classical monocyte state43 or alternatively, that only a fraction of Ly6cHi monocytes are 
required to maintain Ly6cLo monocytes40. Further work will be needed to determine whether the developmental 
trajectories of monocytes change in the setting of perinatal liver inflammation, and whether the fetal environment 
is conducive to a pro-reparative state through the preferential expansion of Ly6cLo non-classical monocytes.
One of the main limitations of the RRV model of periportal injury is that it is restricted to the Balb/c strain; 
RRV infection in C57BL/6 (B6) and 129 pups yields inconsistent and milder levels of inflammation (data not 
shown). As a result of its restricted phenotype in Balb/c animals and the predominance of transgenic immune 
deficient strains on the B6 background, manipulating immune populations is only possible after backcrossing 
transgenic strains on the B6 background to Balb/c, which can be a time-consuming endeavor. Alternative mono-
cyte depletion strategies, including the use of clodronate liposomes, does not deplete monocytes in the liver 
despite efficient depletion of circulating monocytes (data not shown). Genetic strategies to render animals absent 
of Ly6cLo non-classical monocytes have been reported44, but we have found circulating Ly6cLo non-classical mono-
cytes, albeit at lower frequencies, in Nr4a1-deficient animals (data not shown). Although use of AZD8797 did 
lead to the observation of a reduction of Ly6cLo non-classical monocytes along with restoration of susceptibility to 
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RRV-mediated inflammation, based on the known expression of Cx3cr1 on monocyte-derived pro-inflammatory 
macrophages45, we cannot exclude the possibility that monocyte-derived macrophages play a role in RRV sus-
ceptibility. Our data, however, consistently demonstrates a survival benefit when Ly6cLo non-classical monocytes 
outnumber Ly6cHi classical monocytes in the setting of perinatal inflammation.
Here, we demonstrate that Ly6cLo non-classical monocytes promote resolution of RRV-mediated perinatal 
liver inflammation in both the physiologic environment of the late gestation fetus, and in the neonatal pup. These 
data support the use of targeted therapies that can enhance Ly6cLo non-classical monocyte function to mitigate 
the detrimental effects of perinatal liver inflammation.
Methods
Mice. Balb/c and C57BL/6 wildtype mice were obtained from the National Cancer Institute (Wilmington, 
MA). BALB/c.RAG KO (RAG KO) mice were purchased from Taconic Biosciences (Rensselaer, NY). All mouse 
experiments were approved by the UCSF Institutional Animal Care and Use Committee, and animals received 
humane care in accordance with the criteria outlined in the Guide for the Care and Use of Laboratory Animals.
Creation of single-cell suspensions from fetal and neonatal livers. Livers and spleens were isolated 
from euthanized mice, washed with PBS and processed. To create single cell suspensions, spleens from all pups, 
regardless of age, and livers from pups younger than P7 were homogenized by gentle mechanical dissociation. 
Livers from pups older than P7 were dissociated using enzymatic digestion with 2.5 mg/ml Liberase (Roche, 
Indianapolis, IN, 05401119001) in 1 M CaCl2 HEPES Buffer.
Single-cell RNA sequencing. For single-cell RNA sequencing, single cell suspensions were made from 
C57/BL6 mouse fetal livers at E15.5, E17.5, and P0. Single cells were sequenced with 10x Genomics’ droplet-based 
method46. CellRanger 2.1.1 was used to align raw reads and filter cell barcodes. Replicate samples were pooled 
together. Quality control, principal component analysis, clustering, and differential expression analysis were per-
formed in R with Seurat (v3.0)46. Cells with less than 200 genes, unique molecular identifier count of less than 
500 or greater than 20000, and greater than 25% of total expression from mitochondrial genes were excluded 
from analysis. The computational tool, SingleR (v0.2.2), was used to identify cell types in an unbiased fashion 
using reference data sets of transcriptomes derived from pure populations10. Based on this annotation, monocytes 
were identified and further sub-clustered. Monocytes with Ly6c2 expression >1.5 (log-normalized counts) were 
classified as Ly6cHi classical monocytes; those with Ly6c2 expression less than 1.5 (log-normalized counts) were 
classified as Ly6cLo non-classical monocytes. Differentially expressed genes between Ly6cHi classical monocytes 
and Ly6cLo non-classical monocytes, determined by a ≥ 0.5 log fold change and p < 0.05, were identified using the 
Wilcoxon Rank Sum test, and were functionally annotated using Reactome11.
Flow cytometry. For flow cytometric analysis, liver and spleen single-cell suspensions were stained using 
the following antibodies: Cd11c, clone N418 (Biolegend, San Diego, CA, 117339); Ly6c, clone HK1.4 (Biolegend, 
128035); MHCII, clone M5/114.15.2 (eBioscience, Waltham, MA, 48-5321-82); Cd45, clone 30-F11 (eBiosci-
ence, 56-0451-82); Cd11b, clone M1/70 (eBioscience, 47-0112-82); Cd64, clone X54-5/7.1 (BD Biosciences, 
Franklin Lakes, NJ, 741024); Ly6g, clone 1A8 (BD Biosciences, 560601); Fc block Cd16/Cd32, clone 2.4G2 (BD 
Biosciences, 553142); Ly6g, RB6-8c5 (Tonbo, San Diego, CA, 60-5931); Ghost (Tonbo, 13-0870-T100); Flow cyto-
metric data was acquired on the BD LSRII Fortessa X20 and analyzed using FlowJo (Franklin Lakes, NJ).
Postnatal and fetal models of perinatal inflammation. Rhesus rotavirus (RRV) and Cercopithecus 
aethiops kidney epithelial cells (MA104) cells were obtained from Dr. Henry Greenberg (Stanford University, Palo 
Alto, CA). Virus was grown and titered in MA104 cells. To induce postnatal hepatic inflammation, P0 pups were 
injected intraperitoneally with 1.5 ×106 focus forming units (ffu) 24 hours after delivery. Postnatal animals were 
also treated with depleting antibodies for Ly6cHi classical monocytes (anti-Ccr2, clone MC21) at a dose of 2 mg/
kg and neutrophils (anti-Ly6g, clone 1A8, BioXCell, West Lebanon, NH) at a dose of 5 mg/kg, or a small molecule 
inhibitor to Cx3cr1 to ablate Ly6cLo non-classical monocytes function (AZD8797, Axon Medchem, Reston, VA) 
at a dose of 16 mg/kg. For fetal injections, dams underwent survival surgery to expose the uterus and fetuses as 
previously described16,17. Fetuses received intrahepatic injections of 1.5 ×106 ffu of RRV. Controls were injected 
with PBS using the same technique. Pups were weighed daily, and were observed for survival, activity, size, fur 
distribution, yellow discoloration of mucosal surfaces, and urine or stool color changes. Animals that appeared 
moribund were sacrificed.
Viral titration assay. Samples of infected whole livers were weighed and homogenized using a glass tissue 
homogenizer in serum-free media. Ten-fold serial dilutions of liver homogenates were added to a confluent layer 
of MA104 cells grown in 6-well plates (1 sample/well). RRV stock and uninfected liver samples were used as posi-
tive and negative controls, respectively. Samples were incubated for 1 hour in 5% CO2 and 37 °C. After incubation, 
the liver homogenate was aspirated, and agarose in serum-free media (0.6% agarose, 2X M199, 0.45% NaHCO3, 
0.5 ug/ml trypsin, 1% penicillin/streptomycin, 1% L-glutamine) were added to each well. Once agarose solidified, 
the plates were incubated in 5% CO2 and 37 °C. On the following 3rd morning, plates were stained with 0.5% neu-
tral red solution, incubated in 5% CO2 and 37 °C for 5 hours, and plaques were then counted. Viral titer per mg of 
tissue was calculated using the following equation: (# of plaques x viral volume x dilution factor)/sample weight.
Histologic assessment of RRV-infected tissues. Hematoxylin and eosin tissue sections were assessed by 
a blinded board certified pathologist with specialization in Liver pathology. Histologic liver sections were assessed 
for presence of inflammation and fibrosis using the Batts-Ludwig methodology47. In addition, centrizonal necrosis 
and extramedullary hematopoiesis within the liver were assessed and graded using a range of 0 to 4.
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Statistics and data analysis. Graphpad Prism 8.0 (San Diego, CA) was used to generate graphs and per-
form statistical analysis. An unpaired t-test with Welch’s correction was used for comparing 2 groups. When com-
paring 2 groups that were not normally distributed, the non-parametric Mann-Whitney test was used. A one-way 
ANOVA with Tukey’s multiple comparisons test was used to compare multiple groups. The Chi-square test was 
used to compare differences in proportions between two groups. Survival was evaluated using the log-rank 
(Mantel-Cox) test. Quantification of myeloid populations after Ab-mediated depletion was calculated by dividing 
the number of live cells of interest by organ weight.
Data availability
The authors declare that all other data supporting the findings of this study are available within the article and its 
Supplementary Information Files.
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